Roughly 10 percent of the U.S. population is afflicted with major depressive disorder at any given time, and up to 20 percent will exhibit MDD symptoms over their lifetimes.
Yet despite its prevalence, methods to treat MDD often fall short for a not-insignificant portion of the population. Antidepressants — the standard of treatment — don’t work for 30 percent with MDD.
When infused at a low dose ketamine shows remarkable efficacy as a rapidly acting antidepressant, with effects observed…
Continue Reading
News Source: www.sciencedaily.com
Leave a Reply